Metatarsus adductus (MTA) affects around one out of every 100 newborns. Although most malformations heal independently, moderate and severe deformities may cause future suffering; thus, they are frequently corrected. Stretching, serial casting, and orthoses are all standard therapy options. Surgery is reserved for severe instances that have failed to respond to non-surgical treatment. UNFO is a ground-breaking approach designed to treat Severe Metatarsus Varus, Metatarsus Adductus (Severe, Moderate, and Mild), Forefoot Adduction, and Pigeon Toes in infants. UNFO tackles the challenges and stress associated with repeated casting, the ineffectiveness of stretching, and the resulting under- or overtreatment of Metatarsus Adductus. 
The Universal Neonatal Foot Orthotic (UNFO) is a Velcro-strapped pre-molded corrective shoe developed to treat infants' metatarsus adductusv (MTA). The gadget has a six-point rotating foot brace and a free ankle joint, as well as an effective and time-saving therapy. There are no difficulties with UNFO, resulting in great compliance and eliminating the necessity for casting. UNFO is considerably better, safer, and less stressful than serial casting for the treatment of MTA of any severity. Furthermore, UNFO puts the treatment of mild to moderate patients in the hands of the physician, rather than depending on the parents' ability to appropriately conduct stretching exercises on their baby's feet several times a day for weeks or months as a compromised "wait-and-see" approach. UNFO eliminates the danger of failing to treat newborns with MTA promptly because there is no need to "wait and see" whether stretching is a helpful treatment for the child. Additionally, parents may rest confident that their infant will be treated right from the start with UNFO. The patient receives a new and cutting-edge therapy, while the physician earns credibility and can treat various types of MTA successfully. The UNFO brace is a below-the-ankle short foot orthotic device. It has a great fit and grip, and it corrects the malformed foot with 6-point multidirectional forces. The UNFO sandal-like brace is fitted on the patient's foot, which is cushioned with a sock. The device must be worn 23 hours per day for the first six weeks of treatment, and it can be removed two times per day for no more than half an hour. 
The amount of tension needed for the therapy will be marked on the strap by the physician. The parent can remove the UNFO foot brace for a half-hour in the morning and evening to bathe the infant. During the first six weeks of therapy, the doctor examines the infant's foot every two weeks and adjusts the strap as needed. Notably, to avoid relapse, the orthotic device should only be used at night after around six weeks of finished therapy. For adults suffering from MTA, it can be rectified by getting metatarsus adductus shoes. The best shoes for the metatarsus adductus (MTA) should include a specific injection-molded memory retention outsole and midsole to improve support and high-level cushioning. A flexible rubber outsole should also be included to prevent Metatarsus Adductus victims' feet from acute underfoot discomfort caused by ankle sprains. Additionally, to save your foot from grinding, good metatarsus adductus shoes should include a dual-density Soft collar. Furthermore, after a metatarsus adductus operation, a pair with a memory foam insole is believed to be the most comfortable. Every stride you take absorbs pressure, impact force, and shock, lessening the bodyweight strain on your feet.
Reviewed by
